Last reviewed: June 4, 2026
Last updated: June 4, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has demonstrated the ability to produce weight loss of 15-22% in clinical trials when patients reach their target maintenance dose. But knowing which maintenance dose will work best for your body requires understanding how your individual metabolism responds to GLP-1 therapy.
Start a Semaglutide program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded Semaglutide, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.
Start your intake →
Understanding Semaglutide Maintenance vs. Titration Phase
Most semaglutide treatment plans follow a structured approach: a titration phase where doses gradually increase, followed by a maintenance phase where you stay at an effective dose. During titration, patients typically start at lower amounts and increase every four weeks to find tolerability and effectiveness. The maintenance phase begins once you've identified the dose producing meaningful appetite suppression and weight loss without intolerable side effects.
The transition from titration to maintenance typically occurs between weeks 8 and 16 of treatment. At this point, your appetite regulation has stabilized, and your body has adapted to the medication's effects. Remaining at your maintenance dose allows your weight loss trajectory to continue steadily without the discomfort that sometimes accompanies dose increases during the initial phase.
Typical Semaglutide Maintenance Dose Ranges
Clinical evidence suggests that semaglutide maintenance doses most commonly range from 1.0 mg to 2.4 mg weekly for injectable forms, though some patients achieve excellent results at lower doses. The STEP trials, which established semaglutide's effectiveness for chronic weight management, showed that participants on 2.4 mg weekly lost significantly more weight than those on placebo or lower doses. However, individual responses vary considerably, and not every person requires the maximum dose for optimal results.
Your ideal maintenance dose depends on several factors: how much weight you need to lose, your baseline metabolism, your tolerance for side effects, and your appetite response to the medication. Some patients maintain meaningful weight loss at 0.5 mg or 1.0 mg weekly, while others find they need doses at the higher end of the range. PlexusDx takes a personalized approach by evaluating your individual profile rather than assuming one dose fits all patients.
How Your Body Signals You've Found the Right Maintenance Dose
The right maintenance dose produces consistent appetite suppression without causing excessive nausea, vomiting, or gastrointestinal distress. You'll notice steady weight loss week-to-week, decreased cravings for food you previously struggled to resist, and satisfaction with smaller meal portions. Many patients report feeling fuller faster and experiencing genuine disinterest in foods that previously triggered overeating—this is the sign that your dose is working effectively at the appetite-regulation level.
Another signal you've reached an appropriate maintenance dose is stabilization of your weight loss rate. During the first months, some patients experience rapid weight drops; as the body adapts, the rate typically slows to 1-2 pounds weekly, which is sustainable and healthy. If you plateau entirely or regain weight while on a maintenance dose, that may indicate the need for a dose adjustment upward, or it could reflect changes in your eating patterns or activity level that warrant reassessment.
The Role of Genetic Testing in Optimizing Your Maintenance Dose
The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
By mapping 14 distinct metabolic pathways and evaluating 49 different peptide-related genes, PlexusDx provides clarity on your individual peptide biology. This genetic intelligence allows your provider to make more informed decisions about your maintenance dose strategy, potentially reducing trial-and-error adjustments and helping you reach your target weight more efficiently. The test adds $298 and complements your clinical progress to create a truly personalized protocol.
Maintaining Long-Term Results at Your Optimal Dose
Once you've established your maintenance dose, consistency becomes essential for sustained weight loss. Taking your weekly injection on the same day each week and maintaining stable eating and activity patterns allows your body to work optimally with the medication. Some patients remain on their maintenance dose indefinitely, while others may need minor adjustments up or down as their metabolism, lifestyle, or weight-loss goals evolve.
PlexusDx supports you throughout your maintenance phase with affordable, predictable pricing: Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan), with your dose potentially increasing as needed—but your price remaining flat. This straightforward cost structure means you can focus on your health without worrying about escalating medication expenses. HSA and FSA funds are accepted, making treatment accessible and financially flexible for most patients across all 50 states.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
What is the most common maintenance dose of semaglutide?
Clinical data indicates that 1.0 mg to 2.4 mg weekly is the typical maintenance range, with 2.4 mg being the maximum studied dose in major trials. However, many patients achieve excellent results at 0.5 mg or 1.0 mg weekly, making the most common dose highly individual.
How long does it take to reach maintenance dose?
The titration phase typically lasts 8-16 weeks, during which your dose increases gradually in 0.25 mg or 0.5 mg increments every four weeks. Once your provider determines you've reached an effective dose with tolerable side effects and meaningful weight loss, you transition to the maintenance phase.
Can I start directly at maintenance dose instead of titrating?
Starting at a high dose without titration significantly increases the risk of severe nausea, vomiting, and gastrointestinal side effects that may cause treatment discontinuation. The gradual titration approach allows your digestive system to adapt and helps you identify the lowest effective dose for your body.
Does PlexusDx charge more if my dose increases over time?
No. PlexusDx pricing is flat per medication, not per dose. Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) regardless of whether you're on 0.5 mg or 2.4 mg weekly. This transparent pricing means your dose may go up, but your monthly cost remains consistent, making long-term treatment predictable and affordable.
How can genetic testing help me find my ideal maintenance dose?
The PlexusDx Precision Peptide Genetic Test identifies variants in genes like GIPR, FTO, and MC4R that influence your metabolic response to semaglutide.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Will .25 Ozempic Help Lose Weight? Exploring the Impact of Semaglutide on Weight Loss
Why Do GLP-1 Medications Cause Constipation?